These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 22453734)

  • 21. Interferon-beta increases BAFF levels in multiple sclerosis: implications for B cell autoimmunity.
    Krumbholz M; Faber H; Steinmeyer F; Hoffmann LA; Kümpfel T; Pellkofer H; Derfuss T; Ionescu C; Starck M; Hafner C; Hohlfeld R; Meinl E
    Brain; 2008 Jun; 131(Pt 6):1455-63. PubMed ID: 18474519
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Elevated serum BAFF levels are associated with rising anti-double-stranded DNA antibody levels and disease flare following B cell depletion therapy in systemic lupus erythematosus.
    Carter LM; Isenberg DA; Ehrenstein MR
    Arthritis Rheum; 2013 Oct; 65(10):2672-9. PubMed ID: 23839909
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modifications of the BAFF/BAFF-Receptor Axis in Patients With Pemphigus Treated With Rituximab Versus Standard Corticosteroid Regimen.
    Hébert V; Maho-Vaillant M; Golinski ML; Petit M; Riou G; Boyer O; Musette P; Calbo S; Joly P
    Front Immunol; 2021; 12():666022. PubMed ID: 34054835
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of end-stage renal disease on B-lymphocyte subpopulations, IL-7, BAFF and BAFF receptor expression.
    Pahl MV; Gollapudi S; Sepassi L; Gollapudi P; Elahimehr R; Vaziri ND
    Nephrol Dial Transplant; 2010 Jan; 25(1):205-12. PubMed ID: 19684120
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Toll-like receptor 9 activation induces expression of membrane-bound B-cell activating factor (BAFF) on human B cells and leads to increased proliferation in response to both soluble and membrane-bound BAFF.
    Abu-Rish EY; Amrani Y; Browning MJ
    Rheumatology (Oxford); 2013 Jul; 52(7):1190-201. PubMed ID: 23436580
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Soluble BAFF Cytokine Levels and Antibody-Mediated Rejection of the Kidney Allograft.
    Slavcev A; Brozova J; Slatinska J; Sekerkova Z; Honsova E; Skibova J; Striz I; Viklicky O
    Arch Immunol Ther Exp (Warsz); 2016 Dec; 64(Suppl 1):47-53. PubMed ID: 28083608
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of B-cell activating factor of the tumour necrosis factor family (BAFF) in T cells in active systemic lupus erythematosus: the role of BAFF in T cell-dependent B cell pathogenic autoantibody production.
    Morimoto S; Nakano S; Watanabe T; Tamayama Y; Mitsuo A; Nakiri Y; Suzuki J; Nozawa K; Amano H; Tokano Y; Kobata T; Takasaki Y
    Rheumatology (Oxford); 2007 Jul; 46(7):1083-6. PubMed ID: 17500077
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum B-cell activating factor assessment in a population of Egyptian patients with systemic sclerosis.
    Abdo MS; Mohammed RH; Raslan HM; Gaber SM
    Int J Rheum Dis; 2013 Apr; 16(2):148-56. PubMed ID: 23639027
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Soluble BAFF levels inversely correlate with peripheral B cell numbers and the expression of BAFF receptors.
    Kreuzaler M; Rauch M; Salzer U; Birmelin J; Rizzi M; Grimbacher B; Plebani A; Lougaris V; Quinti I; Thon V; Litzman J; Schlesier M; Warnatz K; Thiel J; Rolink AG; Eibel H
    J Immunol; 2012 Jan; 188(1):497-503. PubMed ID: 22124120
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum BAFF and APRIL Levels, T-Lymphocyte Subsets, and Immunoglobulins after B-Cell Depletion Using the Monoclonal Anti-CD20 Antibody Rituximab in Myalgic Encephalopathy/Chronic Fatigue Syndrome.
    Lunde S; Kristoffersen EK; Sapkota D; Risa K; Dahl O; Bruland O; Mella O; Fluge Ø
    PLoS One; 2016; 11(8):e0161226. PubMed ID: 27536947
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum BAFF levels and skin mRNA expression in patients with Behçet's disease.
    Hamzaoui K; Houman H; Ben Dhifallah I; Kamoun M; Hamzaoui A
    Clin Exp Rheumatol; 2008; 26(4 Suppl 50):S64-71. PubMed ID: 19026118
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effects of BAFF and BAFF-R-Fc fusion protein in immune thrombocytopenia.
    Zhu XJ; Shi Y; Peng J; Guo CS; Shan NN; Qin P; Ji XB; Hou M
    Blood; 2009 Dec; 114(26):5362-7. PubMed ID: 19794139
    [TBL] [Abstract][Full Text] [Related]  

  • 33. B-cell-activating factor receptor expression on naive and memory B cells: relationship with relapse in patients with rheumatoid arthritis following B-cell depletion therapy.
    de la Torre I; Moura RA; Leandro MJ; Edwards J; Cambridge G
    Ann Rheum Dis; 2010 Dec; 69(12):2181-8. PubMed ID: 20581016
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Peripherally circulating CD4⁺ FOXP3⁺ CXCR3⁺ T regulatory cells correlate with renal allograft function.
    Hoerning A; Köhler S; Jun C; Tebbe B; Fu J; Menke J; Wilde B; Dolff S; Feldkamp T; Briscoe DM; Kribben A; Hoyer PF; Witzke O
    Scand J Immunol; 2012 Sep; 76(3):320-8. PubMed ID: 22670785
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical Significance of Pre- and Post-Transplant BAFF Levels in Kidney Transplant Recipients.
    Min JW; Kim KW; Kim BM; Doh KC; Choi MS; Choi BS; Park CW; Yang CW; Kim YS; Oh EJ; Chung BH
    PLoS One; 2016; 11(9):e0162964. PubMed ID: 27631619
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High levels of B-cell activating factor in patients with active chronic graft-versus-host disease.
    Sarantopoulos S; Stevenson KE; Kim HT; Bhuiya NS; Cutler CS; Soiffer RJ; Antin JH; Ritz J
    Clin Cancer Res; 2007 Oct; 13(20):6107-14. PubMed ID: 17947475
    [TBL] [Abstract][Full Text] [Related]  

  • 37. B-cell activating factor BAFF reflects patients' immunological risk profile after kidney transplantation.
    Schuster A; Jung B; Hofbauer J; Kühne L; Zecher D; Banas B; Bergler T
    Transpl Immunol; 2017 Dec; 45():35-41. PubMed ID: 28867309
    [TBL] [Abstract][Full Text] [Related]  

  • 38. BAFF/APRIL system in pediatric OMS: relation to severity, neuroinflammation, and immunotherapy.
    Pranzatelli MR; Tate ED; McGee NR; Travelstead AL; Colliver JA; Ness JM; Ransohoff RM
    J Neuroinflammation; 2013 Jan; 10():10. PubMed ID: 23324534
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum BAFF predicts prognosis better than APRIL in diffuse large B-cell lymphoma patients treated with rituximab plus CHOP chemotherapy.
    Kim SJ; Lee SJ; Choi IY; Park Y; Choi CW; Kim IS; Yu W; Hwang HS; Kim BS
    Eur J Haematol; 2008 Sep; 81(3):177-84. PubMed ID: 18510703
    [TBL] [Abstract][Full Text] [Related]  

  • 40. B-cell-activating factor code and human cytomegalovirus infection in renal transplant recipients.
    Xu H; Dong P; He X; Ma X; Xue D; Zhang Y; Zhang X
    Microbiol Immunol; 2014 Aug; 58(8):439-48. PubMed ID: 24931438
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.